Market Overview

Raymond James Downgrades Meridian Bioscience To Underperform

Share:

Analysts at Raymond James downgraded Meridian Bioscience, Inc. (NASDAQ: VIVO) from Market Perform to Underperform.

Meridian Bioscience shares have dropped 36.96% over the past 52 weeks, while the S&P 500 index has gained 12.39% in the same period.

Meridian Bioscience's shares rose 0.86% to close at $16.46 on Wednesday.

Latest Ratings for VIVO

DateFirmActionFromTo
May 2019MaintainsSellSell
May 2019UpgradesUnderweightNeutral
Apr 2019DowngradesHoldSell

View More Analyst Ratings for VIVO
View the Latest Analyst Ratings

Posted-In: Raymond JamesDowngrades Analyst Ratings

 

Related Articles (VIVO)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
YEXTMorgan StanleyMaintains15.0
WKMorgan StanleyMaintains42.0
RAMPMorgan StanleyMaintains58.0
PDMorgan StanleyMaintains34.0
HTHTDaiwa CapitalDowngrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Form 8-K Shows Cubist Notice of Failure For CVR Agreement

Keefe, Bruyette & Woods Cleans Up Capital Structure For Park National